Aicardi-Goutières syndrome (AGS)
- PMID: 18343173
- DOI: 10.1016/j.ejpn.2007.11.010
Aicardi-Goutières syndrome (AGS)
Abstract
In 1984, Jean Aicardi and Françoise Goutières described 8 children showing both severe brain atrophy and chronic cerebrospinal fluid lymphocytosis, with basal ganglia calcification in at least one member of each affected family. The course was rapid to death or a vegetative outcome. Aicardi and Goutières correctly predicted that the disorder would be genetic, but emphasised that "some features, especially the pleocytosis, may erroneously suggest an inflammatory condition". The increased interferon-alpha in affected children (Pierre Lebon, Paris) mimicked congenital viral infection, but the associated chilblains (pernio) pointed to lupus erythematosus and an autoimmune mechanism. Genetic research led by Yanick Crow has clarified these puzzling relationships in Aicardi-Goutières syndrome, a syndrome that now includes conditions previously known as microcephaly-intracranial calcification syndrome, pseudo-TORCH and Cree encephalitis. At the time of writing, Crow's team has discovered that over 80% of families with Aicardi-Goutières syndrome have mutations in one of four nuclease genes, the exonuclease TREX1 and the genes for all three subunits of the ribonuclease H2 enzyme complex. Aicardi-Goutières syndrome is both genetically and phenotypically heterogeneous, with a range of severity from life-threatening perinatal illness to mild late infancy onset. All infants of whatever genotype have increased interferon-alpha in the first year of life and this appears to be the final common pathway that links Aicardi-Goutières syndrome, congenital virus infection and systemic lupus erythematosus.
Similar articles
-
Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in Aicardi-Goutieres syndrome.J Child Neurol. 2012 Jan;27(1):51-60. doi: 10.1177/0883073811413582. Epub 2011 Aug 23. J Child Neurol. 2012. PMID: 21862834
-
Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.Arthritis Rheum. 2010 May;62(5):1469-77. doi: 10.1002/art.27367. Arthritis Rheum. 2010. PMID: 20131292
-
Aicardi-Goutières syndrome: description of a late onset case.Dev Med Child Neurol. 2008 Aug;50(8):631-4. doi: 10.1111/j.1469-8749.2008.03033.x. Dev Med Child Neurol. 2008. PMID: 18754903
-
Aicardi-Goutières syndrome.Brain Dev. 2005 Apr;27(3):201-6. doi: 10.1016/j.braindev.2003.12.011. Brain Dev. 2005. PMID: 15737701 Review.
-
Aicardi-Goutières syndrome: differential diagnosis and aetiopathogenesis.Funct Neurol. 2003 Apr-Jun;18(2):71-5. Funct Neurol. 2003. PMID: 12911136 Review.
Cited by
-
Navigating the brain and aging: exploring the impact of transposable elements from health to disease.Front Cell Dev Biol. 2024 Feb 27;12:1357576. doi: 10.3389/fcell.2024.1357576. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38476259 Free PMC article. Review.
-
Novel RNASEH2C mutation in multiple members of a large family: insights into phenotypic spectrum of Aicardi-Goutières Syndrome.BMJ Neurol Open. 2020 Jan 14;2(1):e000018. doi: 10.1136/bmjno-2019-000018. eCollection 2020. BMJ Neurol Open. 2020. PMID: 33681774 Free PMC article.
-
Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.J Child Neurol. 2021 Jan;36(1):65-78. doi: 10.1177/0883073820946154. Epub 2020 Sep 2. J Child Neurol. 2021. PMID: 32875938 Free PMC article. Review.
-
Too much of a good thing: Detrimental effects of interferon.Semin Immunol. 2019 Jun;43:101282. doi: 10.1016/j.smim.2019.101282. Semin Immunol. 2019. PMID: 31771763 Free PMC article. Review.
-
Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease.Mob DNA. 2019 Jul 26;10:32. doi: 10.1186/s13100-019-0176-1. eCollection 2019. Mob DNA. 2019. PMID: 31372185 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases